VoICE Immunization Evidence: Return on investment
Vaccination programs such as those for Rotavirus have shown a significant short-term return on investment.
In a UK cost-effectiveness analysis, which takes into account herd effect, the budget impact analysis demonstrated that the introduction of a rotavirus vaccine (RVV) program could pay back between 58-96% of the cost outlay for the program within the first 4 years.
Atkins, K.E., Carroll, S., et al. 2012. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.. Vaccine. 30(48), 6766.
In an economic evaluation of vaccination against rotavirus conducted in Italy, it was shown that as early as the second year after rotavirus vaccine introduction, the vaccine cost would be more than offset by savings from prevention of disease cases and hospitalizations.
Carroll, S., García Rojas, A. J., et al. 2015. Vaccination: short- to long-term benefits from investment. Market Access & Health Policy. 3: 27279.